PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsneuroendocrine carcinoma
MeSH D018278 - neuroendocrine carcinoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D018358:Neuroendocrine tumors
15 Companies
7 Drugs
$
Success rate
D000230:Adenocarcinoma
24 Companies
3 Drugs
$
Success rate
D018278: 
Neuroendocrine carcinoma
0 Companies
0 Drugs
Success rate
D003969:Vipoma
0 Companies
0 Drugs
Success rate
D013005:Somatostatinoma
0 Companies
0 Drugs
Success rate
D015266:Merkel cell carcinoma
3 Companies
2 Drugs
$
Success rate
D018276:Medullary carcinoma
6 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
81%
22/27
Phase 2
13%
9/71
Phase 3
0%
0/10
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use